Rapport Therapeutics Price Chart
Rapport Therapeutics Volume Chart
Rapport Therapeutics Market Segments
After Hours
+0.00(+0.00%)
| Open | $28.25 |
|---|---|
| Close | $28.25 |
| Low | $28.25 |
| Low Change | 0.00 (0.00%) |
| High | $28.25 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1.807K |
| Dollar Volume | $51.05K |
Regular Trading Hours
+0.68(+2.46%)
| Open | $27.61 |
|---|---|
| Close | $28.29 |
| Low | $26.98 |
| Low Change | -0.64 (-2.30%) |
| High | $28.30 |
| High Change | +0.69 (+2.50%) |
| Range | $1.33 |
| Volume | 127.112K |
| Dollar Volume | $3.60M |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $27.91 |
|---|---|
| Close | $27.91 |
| Low | $27.91 |
| Low Change | 0.00 (0.00%) |
| High | $27.91 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 175 |
| Dollar Volume | $4.88K |
Regular Trading Hours Yesterday
+0.13(+0.47%)
| Open | $27.80 |
|---|---|
| Close | $27.93 |
| Low | $26.96 |
| Low Change | -0.84 (-3.02%) |
| High | $28.36 |
| High Change | +0.56 (+2.01%) |
| Range | $1.40 |
| Volume | 239.239K |
| Dollar Volume | $6.68M |
Premarket Yesterday
-0.06(-0.22%)
| Open | $27.28 |
|---|---|
| Close | $27.22 |
| Low | $27.22 |
| Low Change | -0.06 (-0.22%) |
| High | $27.28 |
| High Change | +0.00 (+0.00%) |
| Range | $0.06 |
| Volume | 368 |
| Dollar Volume | $10.02K |
Rapport Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $27.36 |
|---|---|
| 10 Day Moving Average (SMA10) | $28.12 |
| 20 Day Moving Average (SMA20) | $28.77 |
| 50 Day Moving Average (SMA50) | $28.03 |
| 100 Day Moving Average (SMA100) | $28.10 |
| 200 Day Moving Average (SMA200) | $23.11 |
Rapport Therapeutics Statistics
| Average Volume (30 Days) | 341.2K |
|---|---|
| P/E Ratio (Current) | -11.57 |
| EPS (Current) | -$2.34 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$88.09M |
| Cash Ratio | 2.76 |
| Current Ratio | 26.17 |
| Quick Ratio | 26.17 |
| Debt to Equity | 0.00 |
| Enterprise Value | $1.24B |
| EV to EBITDA | -9.98 |
| EV to Sales | — |
| Price to Book | 2.66 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.22% |
| Return on Equity | -0.23% |
Rapport Therapeutics Stock Splits
There have been no stock splits for Rapport Therapeutics (RAPP).
Rapport Therapeutics Dividends
There have been no dividends for Rapport Therapeutics (RAPP).